Dermatological Cancer
-
BRAF-mutant Melanoma – The COLUMBUS Trial
Reinhard DummerEuropean Oncology & Haematology. 2018;14(2):78–9 DOI: https://doi.org/10.17925/EOH.2018.14.2.78 -
Combined BRAF and MEK Inhibition with Vemurafenib and Cobimetinib for Patients with Advanced Melanoma
Antonio M Grimaldi, Ester Simeone, Lucia Festino, Vito Vanella, Paolo A AsciertoEuropean Oncology & Haematology, 2017;13(1):61-5. DOI: https://doi.org/10.17925/EOH.2017.13.01.1a